FAM111B and colorectal cancer: Our results showed that, in vitro, advanced glycation end products (AGEs) promoted CA, migration, and invasion of HCT116 colorectal cancer cells, with the highest CA level in the migrated cell fraction, and upregulated FAM111B, which promoted epithelial–mesenchymal transition.